Targeted therapies for T-cell acute lymphoblastic leukaemia (T-ALL): what makes T-ALL TYK?

Research output: Contribution to journalEditorialOtherpeer-review

Original languageEnglish
Pages (from-to)169-170
Number of pages2
JournalBritish Journal of Haematology
Volume177
Issue number2
DOIs
Publication statusPublished - 1 Apr 2017

Keywords

  • inhibitor
  • T-cell acute lymphoblastic leukaemia
  • TYK2

Cite this